Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology.

The interest of drug delivery has focused on the creation of new formulations with improved properties, taking much attention to the drug release from the carrier. Liposomes have already been commercialized, while dendrimers and hyperbranched polymers are emerging as potentially ideal drug delivery vehicles. Chimeric advanced drug delivery nano systems (chi-aDDnSs) are mixed nanosystems combining different biomaterials that can offer advantages as drug carriers. Alkannin and shikonin (A/S) are naturally occurring hydroxynaphthoquinones with a well-established spectrum of wound healing, antimicrobial, anti-inflammatory, antioxidant and recently established antitumor activity. In this work three generations of hyperbranched aliphatic polyesters were used for the first time to form complexes with shikonin, as well as liposomal chi-aDDnSs. Characterization of the shikonin-loaded chi-aDDnSs was performed by measuring their particle size distribution, ζ-potential, drug encapsulation efficiency and the in vitro release profile. The analysis revealed sufficient drug encapsulation and appropriately featured release profiles. Chi-aDDnSs were also examined for their physical stability at 4°C. The results are considered promising and could be used as a road map for designing in vivo experiments.

[1]  D. Begley,et al.  Drug delivery and targeting to the CNS - Preface , 2002 .

[2]  V. Samanidou,et al.  Recent Advances in Chemistry, Biology and Biotechnology of Alkannins and Shikonins , 2006 .

[3]  A. Assimopoulou,et al.  Determination of naturally occurring hydroxynaphthoquinone polymers by size-exclusion chromatography , 2002 .

[4]  R. Mülhaupt,et al.  Hyperbranched polyesters and their application in dental composites: monomers for low shrinking composites , 2001 .

[5]  A. Assimopoulou,et al.  Study on isohexenylnaphthazarins polymerization in alkaline media. , 2004, Biomedical chromatography : BMC.

[6]  Xin Chen,et al.  Cellular pharmacology studies of shikonin derivatives , 2002, Phytotherapy research : PTR.

[7]  K. Kono,et al.  Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.

[8]  V. Papageorgiou Naturally occurring isohexenylnaphthazarin pigments: a new class of drugs. , 1980, Planta medica.

[9]  Brigitte Voit,et al.  New developments in hyperbranched polymers , 2000 .

[10]  C. Kiparissides,et al.  Synthesis and release studies of shikonin-containing microcapsules prepared by the solvent evaporation method. , 2003, Journal of microencapsulation.

[11]  Frank Caruso,et al.  Effect of dendrimer on entrapment and release of bioactive from liposomes. , 2002, International journal of pharmaceutics.

[12]  K. Nicolaou,et al.  The Chemistry and Biology of Alkannin, Shikonin, and Related Naphthazarin Natural Products. , 1999, Angewandte Chemie.

[13]  Costas Demetzos,et al.  Type and location of interaction between hyperbranched polymers and liposomes. Relevance to design of a potentially advanced drug delivery nanosystem (aDDnS). , 2011, The journal of physical chemistry. B.

[14]  K. Karatasos,et al.  Association of a weakly acidic anti-inflammatory drug (ibuprofen) with a poly(amidoamine) dendrimer as studied by molecular dynamics simulations. , 2009, The journal of physical chemistry. B.

[15]  元英 林 紫根および当帰の薬理学的研究(第2報) ―色素成分ShikoninならびにAcetylshikoninの薬理作用― , 1977 .

[16]  P. Jansens,et al.  Hyperbranched Polymers as Drug Carriers: Microencapsulation and Release Kinetics , 2006, Pharmaceutical development and technology.

[17]  H. Cheng,et al.  Photochemical decomposition of alkannin/shikonin enantiomers , 1995 .

[18]  Sujatha Kannan,et al.  Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. , 2003, International journal of pharmaceutics.

[19]  D. Tomalia,et al.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.

[20]  K. Dimas,et al.  Shikonin‐loaded liposomes as a new drug delivery system: Physicochemical characterization and in vitro cytotoxicity , 2011 .

[21]  K. Ahn,et al.  Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice. , 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[22]  A. Assimopoulou,et al.  Study on polymerization of the pharmaceutical substances isohexenylnaphthazarins. , 2004, Biomedical chromatography : BMC.

[23]  Yun Zeng,et al.  Inhibitory effect of acetylshikonin on human gastric carcinoma cell line SGC-7901 in vitro and in vivo. , 2009, World journal of gastroenterology.

[24]  C. Panayiotou,et al.  Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications. , 2011, International journal of pharmaceutics.

[25]  Y. Isomura,et al.  Antitumor activity of shikonin and its derivatives. , 1977, Chemical & pharmaceutical bulletin.

[26]  A. Assimopoulou,et al.  Preparation and release studies of alkannin-containing microcapsules , 2004, Journal of microencapsulation.

[27]  W. N.,et al.  The Liposomal Formulation of Doxorubicin , 2005 .

[28]  R. Schiffelers,et al.  Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells. , 2008, International journal of pharmaceutics.

[29]  P. Heegaard,et al.  Dendrimers in drug research. , 2004, Chemical Society reviews.

[30]  Robert Langer,et al.  New frontiers in nanotechnology for cancer treatment. , 2008, Urologic oncology.

[31]  Qun Zhou,et al.  A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells , 2010, Breast Cancer Research and Treatment.

[32]  Di Chen,et al.  Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo , 2009, International journal of cancer.

[33]  H. Stuppner,et al.  Preparative isolation and purification of alkannin/shikonin derivatives from natural products by high-speed counter-current chromatography. , 2009, Biomedical chromatography : BMC.

[34]  T Sakthivel,et al.  Interaction of cationic partial dendrimers with charged and neutral liposomes. , 2001, International journal of pharmaceutics.

[35]  Costas Demetzos,et al.  Thermodynamic and structural characterization of Liposomal-Locked in-Dendrimers as drug carriers. , 2010, Colloids and surfaces. B, Biointerfaces.

[36]  J. He Complex of shikonin and β-cyclodextrins by using supercritical carbon dioxide , 2009 .

[37]  K. Karatasos,et al.  Local Dynamics and Hydrogen Bonding in Hyperbranched Aliphatic Polyesters , 2009 .

[38]  K. Karatasos,et al.  Modeling of hyperbranched polyesters as hosts for the multifunctional bioactive agent Shikonin. , 2011, Physical chemistry chemical physics : PCCP.

[39]  K. Tsubono,et al.  Biotransformation of shikonin by human intestinal bacteria , 1994 .

[40]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[41]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Assimopoulou,et al.  Encapsulation of isohexenylnaphthazarins in cyclodextrins. , 2004, Biomedical chromatography : BMC.

[43]  Narendra Kumar Jain,et al.  Dendrimers in oncology: an expanding horizon. , 2009, Chemical reviews.

[44]  B. R. Steele,et al.  New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy. , 2010, Journal of pharmaceutical sciences.

[45]  Costas Demetzos,et al.  New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers. , 2010, International journal of pharmaceutics.

[46]  P. Oettgen,et al.  Mechanism of inhibition of tumor angiogenesis by β‐hydroxyisovalerylshikonin , 2009, Cancer science.

[47]  A. Assimopoulou,et al.  Alkannins and shikonins: a new class of wound healing agents. , 2008, Current medicinal chemistry.

[48]  Water-soluble degradable hyperbranched polyesters: novel candidates for drug delivery? , 2003, Biomacromolecules.

[49]  R. Epand,et al.  PAMAM dendrimers and model membranes: differential scanning calorimetry studies. , 2005, International journal of pharmaceutics.

[50]  Costas Demetzos,et al.  Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. , 2005, International journal of pharmaceutics.

[51]  William A. Goddard,et al.  Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter , 1990 .

[52]  Donald A Tomalia,et al.  Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.

[53]  É. Boisselier,et al.  Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. , 2010, Chemical reviews.

[54]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.